Key regions: Brazil, India, Australia, United States, United Kingdom
Antiviral drugs are medications that help to treat viral infections by inhibiting the growth of viruses. In Ethiopia, the Antiviral Drugs market is experiencing significant growth due to several factors.
Customer preferences: The demand for Antiviral Drugs in Ethiopia is driven by the increasing prevalence of viral infections such as HIV/AIDS, hepatitis B, and C. Customers in Ethiopia prefer Antiviral Drugs that are effective, affordable, and have minimal side effects. Due to the high cost of imported drugs, customers tend to opt for locally manufactured drugs.
Trends in the market: The Antiviral Drugs market in Ethiopia is experiencing significant growth due to the increasing prevalence of viral infections. The market is expected to continue growing due to the rising awareness of the importance of antiviral drugs in treating viral infections. The government of Ethiopia has also taken steps to increase access to antiviral drugs by subsidizing the cost of certain drugs and increasing funding for healthcare infrastructure.
Local special circumstances: Ethiopia has a large population of people living with HIV/AIDS, which has been a major driver of the Antiviral Drugs market in the country. The government of Ethiopia has implemented several programs to combat the spread of HIV/AIDS, including providing free antiretroviral therapy to those living with the virus. Additionally, the country has a high prevalence of hepatitis B and C, which has also contributed to the growth of the Antiviral Drugs market.
Underlying macroeconomic factors: Ethiopia is one of the fastest-growing economies in Africa, with a growing middle class and an expanding healthcare sector. The government of Ethiopia has made significant investments in healthcare infrastructure, which has increased access to healthcare services, including antiviral drugs. Additionally, the pharmaceutical industry in Ethiopia has been growing rapidly, with more local companies entering the market and producing high-quality drugs at affordable prices. This has contributed to the growth of the Antiviral Drugs market in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
